1. Home
  2. AVDL vs DAC Comparison

AVDL vs DAC Comparison

Compare AVDL & DAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Avadel Pharmaceuticals plc

AVDL

Avadel Pharmaceuticals plc

HOLD

Current Price

$21.63

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Logo Danaos Corporation

DAC

Danaos Corporation

HOLD

Current Price

$94.97

Market Cap

1.7B

ML Signal

HOLD

Company Overview

Basic Information
Metric
AVDL
DAC
Founded
2015
1972
Country
Ireland
Greece
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Marine Transportation
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
1.7B
IPO Year
1996
2006

Fundamental Metrics

Financial Performance
Metric
AVDL
DAC
Price
$21.63
$94.97
Analyst Decision
Buy
Strong Buy
Analyst Count
9
1
Target Price
$18.38
$105.00
AVG Volume (30 Days)
2.1M
72.6K
Earning Date
11-04-2025
02-09-2026
Dividend Yield
N/A
3.80%
EPS Growth
N/A
N/A
EPS
N/A
25.05
Revenue
$248,517,000.00
$1,034,370,000.00
Revenue This Year
$65.47
N/A
Revenue Next Year
$30.88
$1.29
P/E Ratio
N/A
$3.78
Revenue Growth
79.88
2.90
52 Week Low
$6.38
$65.40
52 Week High
$23.57
$100.00

Technical Indicators

Market Signals
Indicator
AVDL
DAC
Relative Strength Index (RSI) 61.54 50.58
Support Level $21.36 $92.12
Resistance Level $21.68 $95.40
Average True Range (ATR) 0.12 1.85
MACD -0.12 -0.31
Stochastic Oscillator 74.68 32.36

Price Performance

Historical Comparison
AVDL
DAC

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

About DAC Danaos Corporation

Danaos Corp is an international owner of containerships. It provides international seaborne transportation services by operating vessels in the containership sector of the shipping industry. The company's customers include, HMM, MSC, Yang Ming, Hapag Lloyd, ZIM, Maersk, COSCO, OOCL, ONE, PIL, Sealead, Niledutch, Samudera, OSC, and Arkas. Geographically, the company operates in Australia-Asia, Europe, and America, with maximum revenue from the Australia-Asia region. It has two reporting segments Container vessels and Drybulk vessels segment. It generates the majority of its revenue from Container vessels.

Share on Social Networks: